Challenges In Optimizing Formulations For Multi- Antigen Vaccines,
2012
Pfizer Global R&D
Challenges In Optimizing Formulations For Multi- Antigen Vaccines, Lakshmi Khandke
Vaccine Technology IV
No abstract provided.
A New Successful Vaccine Against Babesiosis: Any Use For Malaria?,
2012
Merck
A New Successful Vaccine Against Babesiosis: Any Use For Malaria?, Thep Schetters
Vaccine Technology IV
No abstract provided.
The Cmc Challenges In Developing An Oncolytic Immunotherapy,
2012
Amgen
The Cmc Challenges In Developing An Oncolytic Immunotherapy, Colin Love
Vaccine Technology IV
No abstract provided.
High Throughput Formulation Design For A Stable Lyophilized Virus-Like Particle Vaccine Against Group A Streptococcu,
2012
The University of Queensland
High Throughput Formulation Design For A Stable Lyophilized Virus-Like Particle Vaccine Against Group A Streptococcu, Yap Chuan
Vaccine Technology IV
No abstract provided.
Process Development For A Peptide Conjugated Qbetavirus Like Particle (Vlp) Vaccine,
2012
Pfizer
Process Development For A Peptide Conjugated Qbetavirus Like Particle (Vlp) Vaccine, Jennifer Thorn
Vaccine Technology IV
No abstract provided.
Formulation And Stability Of A Chikungunya Virus-Like Particle (Chikv Vlp) Based Vaccine,
2012
Vaccine Production Program Laboratory National Institutes of Health
Formulation And Stability Of A Chikungunya Virus-Like Particle (Chikv Vlp) Based Vaccine, Rhicard Schwartz
Vaccine Technology IV
No abstract provided.
Rift Valley Fever: Next Generation Vaccines For An Old Foe,
2012
Viral Special Pathogens Branch Centers for Disease Control and Prevention
Rift Valley Fever: Next Generation Vaccines For An Old Foe, Brian Bird
Vaccine Technology IV
No abstract provided.
Leishmaniasis Vaccine Development: Animals As Models And Patients,
2012
IDRI
Leishmaniasis Vaccine Development: Animals As Models And Patients, Steven Reid
Vaccine Technology IV
No abstract provided.
Biomechanical Testing On Cadaveric Spines For Different Treatments That Affect Lumbar Stability,
2012
University of South Florida
Biomechanical Testing On Cadaveric Spines For Different Treatments That Affect Lumbar Stability, Sabrina Alejandra Gonzalez Blohm
USF Tampa Graduate Theses and Dissertations
Stenosis is one of the most common causes for spinal surgery. Laminectomy decompression and fusion are surgical procedures prescribed for this condition. The intention of this work was to investigate the effects of a laminectomy decompression, followed by fusion, on a lumbar functional spinal unit (FSU) through in vitro dynamic (±8Nm at 0.125Hz) and quasi-static (±7.5Nm at 0.1Hz) biomechanical tests, for flexion, extension, bending and rotation motions.
Six FSUs where disarticulated from four human cadaveric lumbar spines (63 ± 12 years) and were tested under the following sequence: (1) intact, (2) laminectomy decompression, and (3) Pedicle Screw System (PSS), using …
Conference Program,
2012
Engineering Conferences International
Conference Program, Engineering Conferences International
Vaccine Technology IV
No abstract provided.
Tolerogenic Vaccination Exploiting Apoptotic Mechanisms Via Erythrocyte-To- Hepatic/Splenic Targeting,
2012
Institute of Bioengineering, EPFL
Tolerogenic Vaccination Exploiting Apoptotic Mechanisms Via Erythrocyte-To- Hepatic/Splenic Targeting, Jeffrey Hubbell
Vaccine Technology IV
No abstract provided.
Bringing Vaccine Manufacturing Capabilities To The Developing World,
2012
PATH
Bringing Vaccine Manufacturing Capabilities To The Developing World, George Robertson
Vaccine Technology IV
No abstract provided.
Rabies Virus-Like Particles Expressed In Hek293 Cells,
2012
Cell Culture Laboratory Biochemistry and Biological Sciences School Universidad Nacional del Litoral Santa Fe - Argentina
Rabies Virus-Like Particles Expressed In Hek293 Cells, Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray, Claudio Prieto
Vaccine Technology IV
No abstract provided.
Expectation Of China's Contribution To World Vaccine Development And Supplies: Status, Strategy And International Approach,
2012
Shanghai Zerun Biotechnology
Expectation Of China's Contribution To World Vaccine Development And Supplies: Status, Strategy And International Approach, Li Shi
Vaccine Technology IV
No abstract provided.
Process Understanding Approach For A Late-Stage Recombinant Protein Vaccine Produced In Saccharomyces Cerevisiae,
2012
Vaccine Process Development, Merck & Co
Process Understanding Approach For A Late-Stage Recombinant Protein Vaccine Produced In Saccharomyces Cerevisiae, Jose Manuel Otero, Brian Mickus, Amanda Schallop, Brian Doyle, Nedim Altaras
Vaccine Technology IV
No abstract provided.
Challenges In Development Of An Anti-Idiotypic Cancer Vaccine,
2012
Centro de Inmunlogia Molecular
Challenges In Development Of An Anti-Idiotypic Cancer Vaccine, Adolfo Castillo
Vaccine Technology IV
No abstract provided.
The Role Of Public-Private Partnerships In Advancing Vaccine Technologies And Improving Vaccine Effectiveness And Delivery For Developing Countries, Ray Cummings
Vaccine Technology IV
No abstract provided.
Challenges In Batch Production Of Malaria Vaccines,
2012
European Vaccine Initiative
Challenges In Batch Production Of Malaria Vaccines, Nicolas Havelange
Vaccine Technology IV
No abstract provided.
Establishing Human Vaccine Manufacturing In Southern Africa,
2012
The Biovac Institue
Establishing Human Vaccine Manufacturing In Southern Africa, Morena Makhoana
Vaccine Technology IV
No abstract provided.
Rational Design Of A Fully Synthetic Nanoparticle-Based Vaccine For Smoking Cessatio,
2012
Selecta Biosciences
Rational Design Of A Fully Synthetic Nanoparticle-Based Vaccine For Smoking Cessatio, Takashi Kishimoto
Vaccine Technology IV
No abstract provided.
